Andrea Distelrath

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme

Markus Moehler, Annett Maderer, C Schimanski et al. · European Journal of Cancer · 2014 · 135 citations · Full text

Medicine, Oncology, Pharmacology +11

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor‐positive, human epidermal growth factor receptor 2‐negative locally advanced or metastatic breast cancer: Results of the single‐arm, phase IIIB 4EVER trial

Hans Tesch, Oliver J. Stoetzer, Thomas Decker et al. · International Journal of Cancer · 2018 · 42 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial

Nadia Harbeck, Peter A. Fasching, Rachel Wuerstlein et al. · Annals of Oncology · 2023 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17

First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: Results of the MONICA trial

M. Kaufmann, Nicolaì Maass, Serban Dan Costa et al. · European Journal of Cancer · 2010 · 38 citations

Medicine, Oncology, Pharmacology +12

Renal Cell Cancer Presented with Leptomeningeal Carcinomatosis Effectively Treated with Sorafenib

Oliver Ranze, Erich Hofmann, Andrea Distelrath et al. · Oncology Research and Treatment · 2007 · 28 citations

Medicine, Oncology, Metastasis +16